Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02249923 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Study acronym: PPHNet
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: University of Colorado, Denver to New York Medical College
    • Site contacts updated at 14 of 14 sites
    v16
  2. Site contacts updated at 1 of 14 sites
    • Collaborators revised (2)
    v15
  3. Enrollment target: 1000 to 2500
    • Study sites: 8 to 14
    • Study description expanded, about 54 words
    • Collaborators revised (2)
    v14
  4. Re-verified, no change to tracked fieldsv13
  5. Site details revised at 1 of 8 sites
    • Collaborators: 1 to 2
    v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary completion date: Dec 2020 to Dec 2030
    • Study completion date: Jan 2021 to Dec 2031
    • Site contacts updated at 1 of 8 sites
    v11
  2. Primary completion date: Dec 2019 to Dec 2020
    • Study completion date: Jan 2020 to Jan 2021
    v10
  3. Primary completion date: Dec 2018 to Dec 2019
    • Study completion date: Jan 2019 to Jan 2020
    v9
  4. Primary completion date: Oct 2017 to Dec 2018
    • Study completion date: Jan 2018 to Jan 2019
    • Site contacts updated at 1 of 8 sites
    • Study description expanded, about 2 words
    v8
  5. 3 versions Re-verified since Oct 8, 2015, no change to tracked fieldsv5-v7
  6. Site details revised at 1 of 8 sitesv4
  7. Site details revised at 1 of 8 sitesv3
  8. Trial status: Not Yet Recruiting to Recruiting
    • Study description revised
    • Site details revised at 8 of 8 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Trial Details
NCT Number NCT02249923
Lead Sponsor New York Medical College
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Janssen Pharmaceuticals
Conditions
(from sponsor)		 Pulmonary Vascular Disease, Pulmonary Arterial Hypertension
Related terms Pulmonary Arterial Hypertension
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov